Chemotherapy of Experimental and Clinical Cancer

戈登临床实验癌症化疗会议认真尝试将分子和细胞水平的研究科学家与研究整个动物系统的科学家以及临床医生聚集在一起。参与者来自制药行业、临床和生物技术背景，以及学术界。会议旨在通过介绍新的、未发表的工作来促进人类癌症治疗的进步，并集中讨论如何将这些进步应用于患者护理服务。在这项申请中，所寻求的资金将部分用于支持2001年会议。今年的会议将在很大程度上强调新的靶点，试图将传统的靶区(例如DNA修复)置于分子基础上。这些在血管生成、癌基因导向治疗和新的临床试验终点方面出现的机会，将突出进展的方向。

The Gordon Conference on the Chemotherapy of Clinical Experimental Cancer conscientiously attempts to bring research scientists at the molecular and cellular level together with scientists who study whole animal systems, as well as clinicians. Participants come from the pharmaceutical industry, clinical and biotechnology backgrounds, as well as academia. The meeting seeks to promote advancements in the treatment of human cancer through the presentation of novel, unpublished work, and to focus on the ways these advancements can be brought to the service of patient care. In this application, funds are sought to partially support the year 2001 conference. This year's conference will emphasize novel targets for the most part, with an attempt to put traditional target areas (e.g. DNA repair) on a molecular footing. These emerging opportunities in angiogenesis, oncogene- directed therapies, and novel clinical trial endpoints, will highlight directions for progress.